Moreover, Wang et al. explored the impact of glucocerebrosidase mutations, which lead to glucosylceramide accumulation in microglia, triggering STING-dependent neuroinflammation and neuronal loss, thereby linking genetic factors to neuroinflammatory processes (ref: Wang doi.org/10.1126/scisignal.adk8249/). In contrast, Nyame et al. focused on Batten disease, revealing that glycerophosphodiesters accumulate due to CLN3 mutations, although their precise role in neuropathology remains unclear (ref: Nyame doi.org/10.1016/j.molcel.2024.02.006/). This highlights a potential contradiction in understanding the role of lipid metabolism in neuroinflammation, as both studies implicate lipid dysregulation but in different contexts and mechanisms. Collectively, these studies illustrate the complex interplay between genetic, cellular, and immune factors in neuroinflammatory diseases, emphasizing the need for integrated approaches to unravel their pathophysiology.